King's College London

Research portal

Study of the use of antidepressants for depression in dementia: the HTA-SADD trial - a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine

Research output: Contribution to journalArticle

S Banerjee, J Hellier, R Romeo, M Dewey, M Knapp, C Ballard, R Baldwin, P Bentham, C Fox, C Holmes, C Katona, C Lawton, J Lindesay, G Livingston, Niall McCrae, E Moniz-Cook, J Murray, S Nurock, M Orrell, J O'Brien & 5 more M Poppe, A Thomas, R Walwyn, K Wilson, A Burns

Original languageEnglish
Pages (from-to)1-166
Number of pages166
JournalHealth technology assessment (Winchester, England)
Volume17
Issue number7
DOIs
PublishedFeb 2013

King's Authors

Abstract

Depression is common in dementia, causing considerable distress and other negative impacts. Treating it is a clinical priority, but the evidence base is sparse and equivocal. This trial aimed to determine clinical effectiveness of sertraline and mirtazapine in reducing depression 13 weeks post randomisation compared with placebo.

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454